Patents by Inventor Kerstin Krueger

Kerstin Krueger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies against human CSF-1R and uses thereof
    Patent number: 8999327
    Abstract: The present invention relates to antibodies against human CSF-1R (anti-CSF-1R antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.
    Type: Grant
    Filed: December 7, 2010
    Date of Patent: April 7, 2015
    Assignee: Hoffman-La Roche Inc.
    Inventors: Nikolaos Dimoudis, Georg Fertig, Alexander Fidler, Klaus Kaluza, Marlene Pickl, Carola Ries, Stefan Seeber, Kerstin Krueger
  • Antibodies against human CSF-1R and uses thereof
    Patent number: 8900581
    Abstract: The present invention relates to antibodies against human CSF-1R (anti-CSF-1R antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.
    Type: Grant
    Filed: December 7, 2010
    Date of Patent: December 2, 2014
    Assignee: Hoffman-La Roche Inc.
    Inventors: Nikolaos Dimoudis, Georg Fertig, Alexander Fidler, Klaus Kaluza, Marlene Pickl, Carola Ries, Stefan Seeber, Kerstin Krueger
  • ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF
    Publication number: 20110165156
    Abstract: The present invention relates to antibodies against human CSF-1R (anti-CSF-1R antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.
    Type: Application
    Filed: December 7, 2010
    Publication date: July 7, 2011
    Inventors: NIKOLAOS DIMOUDIS, GEORG FERTIG, ALEXANDER FIDLER, KLAUS KALUZA, MARLENE PICKL, CAROLA RIES, STEFAN SEEBER, MARTIN LANZENDOERFER, KERSTIN KRUEGER
  • Method of identifying N-terminal proBNP
    Publication number: 20070059767
    Abstract: The invention relates to a method of identifying N-terminal proBNP in a sample with at least two antibodies that detect different epitopes of the N-terminal proBNP. The method is used to differentiate or classify samples of healthy individuals and samples of patients of NYHA classes I to IV. The invention further relates to recombinant N-terminal proBNP, its use as standard in a method of identifying N-terminal proBNP, to antibodies that detect recombinant N-terminal proBNP and to their production.
    Type: Application
    Filed: August 7, 2006
    Publication date: March 15, 2007
    Inventors: Johann Karl, Helmut Lill, Peter Stahl, Kerstin Krueger, Anneliese Borgya, Andreas Gallusser
  • Recombinant microbial 3-hydroxybutyrate dehydrogenase a process for its production and the use thereof
    Patent number: 6255093
    Abstract: DNA molecule comprising a structural gene which codes for a bacterial protein with the enzymatic activity of 3-hydroxybutyrate dehydrogenase (3-HBDH), a recombinant DNA containing the DNA molecule, microorganisms transformed accordingly, a process for obtaining 3-HBDH by culturing a suitable transformed microorganism as well as a method for the determination of ketone bodies in the presence of the enzyme. A structural gene from Rhodobacter sphaeroides is preferred.
    Type: Grant
    Filed: April 7, 1999
    Date of Patent: July 3, 2001
    Assignee: Roche Diagnostics GmbH
    Inventors: Rainer Schmuck, Rainer Müller, Harald Weisser, Alfred Engel, Kerstin Krüger